BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16382016)

  • 1. Cellular effects of guanylin and uroguanylin.
    Sindić A; Schlatter E
    J Am Soc Nephrol; 2006 Mar; 17(3):607-16. PubMed ID: 16382016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal electrolyte effects of guanylin and uroguanylin.
    Sindić A; Schlatter E
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):10-5. PubMed ID: 17143065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of actions of guanylin peptides in the kidney.
    Sindić A; Schlatter E
    Pflugers Arch; 2005 Aug; 450(5):283-91. PubMed ID: 15952032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
    Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
    Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response.
    Elitsur N; Lorenz JN; Hawkins JA; Rudolph JA; Witte D; Yang LE; McDonough AA; Cohen MB
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S74-81. PubMed ID: 16819406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
    Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
    Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of guanylin peptides actions.
    Sindic A
    ISRN Nephrol; 2013; 2013():813648. PubMed ID: 24967239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pendrin, a novel transcriptional target of the uroguanylin system.
    Rozenfeld J; Tal O; Kladnitsky O; Adler L; Efrati E; Carrithers SL; Alper SL; Zelikovic I
    Cell Physiol Biochem; 2013; 32(7):221-37. PubMed ID: 24429828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron.
    Carrithers SL; Taylor B; Cai WY; Johnson BR; Ott CE; Greenberg RN; Jackson BA
    Regul Pept; 2000 Nov; 95(1-3):65-74. PubMed ID: 11062334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestinal guanylin system and seawater adaptation in eels.
    Takei Y; Yuge S
    Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylin and uroguanylin regulate electrolyte transport in isolated human cortical collecting ducts.
    Sindić A; Hirsch JR; Velic A; Piechota H; Schlatter E
    Kidney Int; 2005 Apr; 67(4):1420-7. PubMed ID: 15780094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
    Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
    Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal and renal guanylin peptides system in hypertensive obese mice.
    Simões-Silva L; Moreira-Rodrigues M; Quelhas-Santos J; Fernandes-Cerqueira C; Pestana M; Soares-Silva I; Sampaio-Maia B
    Exp Biol Med (Maywood); 2013 Jan; 238(1):90-7. PubMed ID: 23479768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanylin and related peptides.
    Bełtowski J
    J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of uroguanylin and guanylin in vivo.
    Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
    Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylin peptides: cyclic GMP signaling mechanisms.
    Forte LR; Freeman RH; Krause WJ; London RM
    Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells.
    Sindiće A; Başoglu C; Cerçi A; Hirsch JR; Potthast R; Kuhn M; Ghanekar Y; Visweswariah SS; Schlatter E
    J Biol Chem; 2002 May; 277(20):17758-64. PubMed ID: 11889121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
    Forte LR
    Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives.
    Fonteles MC; do Nascimento NR
    Can J Physiol Pharmacol; 2011 Aug; 89(8):575-85. PubMed ID: 21815750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.